This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Illumina Corporation. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Ark Silbergleit - Innovator in Nucleic Acid Sequencing
Introduction
Ark Silbergleit is an accomplished inventor based in San Diego, CA. He is currently associated with Illumina Corporation, a leading company in the field of genomics. Although he does not hold any granted patents, his contributions to the field of nucleic acid sequencing are noteworthy.
Latest Patent Applications
Ark Silbergleit has filed a patent application titled "Improvements in Nucleic Acid Sequencing." This application describes a method of preparing templates for high throughput nucleic acid sequencing. The method includes several steps: providing a solid support with a plurality of nucleic acid primers immobilized with adaptor nucleic acid sequences, allowing single-stranded fragments of template nucleic acid to bind to the nucleic acid primers, and repeating these steps multiple times to improve occupation rates of nanowells on a flow cell.
Conclusion
Ark Silbergleit's work at Illumina Corporation and his innovative approach to nucleic acid sequencing highlight his significant role in advancing genomic technologies. His ongoing efforts in this field promise to contribute to future breakthroughs in genetic research.